DB18671InvestigationalSmall molecule
NDX-3315 is an investigational radiopharmaceutical agent for the diagnosis, treatment monitoring, and management of eosinophilic esophagitis. It is a technetium-99m radiolabeled heparin.
- Also known as
- technetium-99m radiolabeled heparin
- Code names
- NDX33-0 · NDX-3315
What you can answer from here — as of April 23, 2025
Which companies are running trials of NDX-3315, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account